Management of Children With Moderate Acute Malnutrition in Mali
- Conditions
- Moderate Acute Malnutrition (MAM)
- Interventions
- Dietary Supplement: MisolaDietary Supplement: Plumpy'SupDietary Supplement: Local food supplementDietary Supplement: SCSB
- Registration Number
- NCT01015950
- Lead Sponsor
- Helen Keller International
- Brief Summary
The objectives of the study are to assess the impact of different dietary strategies for the management of children with MAM on: the children's continued participation in the nutritional rehabilitation program and their physical growth, recovery from MAM, and change in micronutrient status and body composition. The specific dietary regimens that will be compared are: 1) a ready-to-use, lipid-based supplementary food (Plumpy'Sup, Nutriset, Inc.), providing \~500 kcal/d for 12 weeks; 2) specially formulated CSB for malnourished children, providing \~ 500 kcal/d for 12 weeks; 3) Misola, a locally produced, micronutrient-fortified, cereal-legume blend, providing \~500 kcal/d for 12 weeks; or 4) packaged, home available foods (millet and cowpea flour, sugar, vegetable oil) and a multiple micronutrient powder ("Mix Me") for 12 weeks, as is currently recommended by the national CMAM protocol when special foods are not available.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1260
- age from 6 to 35 months,
- MUAC <12.5 cm and >11.0 cm, and weight-for-length (WLZ) Z-score > -3.0 (WHO standard, 2006); or WLZ <-2.0 and >-3.0 and MUAC >11.0 cm
- absence of bi-pedal edema
- absence of current diseases requiring inpatient care
- expected availability during the period of the study
- residency within the study communities
- acceptance of home visitors, and
- written consent of a parent or guardian
- age <6 months or >36 months
- MUAC >12.5 cm and WLZ >-2.0; or MUAC <11.0 cm; or WLZ <-3.0
- presence of bi-pedal edema,
- severe anemia (defined as hemoglobin <50 g/L),
- other acute illnesses requiring inpatient treatment,
- congenital abnormalities or underlying chronic diseases, including known HIV . infection, that may affect growth or risk of infection
- history of allergy towards peanuts or previous serious allergic reaction to . any substance, requiring emergency medical care
- concurrent participation in any other clinical trial
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Misola Misola Locally processed, fortified food blend (Misola) Pumpy'Sup Plumpy'Sup Lipid-based nutrient supplement Local food supplement Local food supplement Local foods (millet flour, cowpea flour, sugar, oil) and a multiple micronutrient powder ("Mix-Me") are provided to simulate the currently recommended enhanced home-prepared rehabilitation food mixture ("farines enrchies") according to the national Mali CMAM protocol. SCSB SCSB Processed, fortified, cereal-based food blend (SCSB for malnourished children)
- Primary Outcome Measures
Name Time Method Weight gain 3 months Continuation in treatment 3 months
- Secondary Outcome Measures
Name Time Method Micronutrient status 3 months Body composition 3 months
Trial Locations
- Locations (1)
Helen Keller International
🇲🇱Bamako, Mali